Kolon "3000 Million USD Third-Party Capital Increase Investment by April Next Year" View original image


[Asia Economy Reporter Moon Chaeseok] Kolon announced on the 21st that it plans to invest 30 million dollars (approximately 43.2 billion KRW) in its affiliate Kolon TissueGene through a third-party allotment paid-in capital increase by April next year.



Kolon stated the purpose of the investment as "to increase the value of the subsidiary by securing clinical funding for Kolon TissueGene."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing